This letter authorises the extended use of the following protocol until 1st September 2018:
|
|
- Brett Casey
- 6 years ago
- Views:
Transcription
1 NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 22nd March 2018 Our Ref: FA/NRTComm/MGPG/Mar18 Enquiries to: Frances Adamson Extension: Direct Line: f.adamsonnhs.net Dear Colleague This letter authorises the extended use of the following protocol until 1st September 2018: NHS Grampian Protocol For The Provision Of Nicotine Replacement Therapy (NRT) For Patients With Nicotine Withdrawal Symptoms In Community Hospital By Registered Nurses The review of this protocol is currently underway and a new Patient Group Direction will be developed to replace this protocol and will be available later in If you have any queries regarding this please do not hesitate to contact the Pharmacy and Medicines Directorate. Yours sincerely C-17. Sandy Thomson Interim Chair of the Medicines Guidelines and Policies Group
2
3 This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) or (01224) This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. Title: Unique Identifier: Replaces: Lead Author/Co-ordinator: Subject (as per document registration categories): Key word(s): Process Document: Policy, Protocol, Procedure or Guideline Document application: Purpose/description: Group/Individual responsible for this document: Policy statement: NHS Grampian Protocol For The Provision Of Nicotine Replacement Therapy (NRT) For Patients With Nicotine Withdrawal Symptoms In Community Hospital By Registered Nurses NHSG/Prot/NRT_InPat/MGPG726 NHSG/Prot/NRT_InPat/MGPG653 Elaine Neil Pharmacist Aberdeenshire CHP/ George Rutten Aberdeenshire Tobacco Lead Protocol Nicotine replacement therapy, NRT, nicotine withdrawal symptoms, smoking cessation, community hospital, minor injuries Protocol NHS Grampian This protocol details how to provide Nicotine Replacement Therapy (NRT) to Community Hospital in-patients who are smokers that cannot smoke while in hospital Head of Health Improvement, NHS Grampian It is the responsibility of all staff to ensure that they are working to the most up to date and relevant policies, protocols procedures. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG726 - i -
4 Responsibilities for ensuring registration of this document on the NHS Grampian Information/ Document Silo: Lead Author/Co-ordinator: Lead Pharmacist, Aberdeenshire CHP Physical location of the Lead Pharmacy, Aberdeenshire CHP original of this document: Job title of creator of this Lead Pharmacist Aberdeenshire CHP document: Job/group title of those who Lead Pharmacist, Aberdeenshire CHP have control over this document: Responsibilities for disseminating document as per distribution list: Lead Author/Co-ordinator: Elaine Neil, Pharmacist Aberdeenshire CHP/George Rutten, Tobacco Lead Aberdeenshire Responsibilities for implementation: Organisational:CHP CHP General Manager Operational Management Units CHP Area Manger Directorate Level CHP Clinical Leads Sector Community Hospital Medical Directors, Community Hospital Mangers Departmental: Clinical Leads Area: Charge Nurse Review frequency and date of next review: This policy will be reviewed at least every two years or sooner if current treatment recommendations change. Responsibilities for review of this document: Lead Author/Co-ordinator: Pharmacist Aberdeenshire CHP/Tobacco Lead Aberdeenshire Revision History: Revision Date February 2015 February 2015 Previous Revision Date April 2014 April 2014 Summary of Changes (Descriptive summary of the changes made) Title amended to refer to all community hospital patients. Protocol now to include minor injury unit patients. Changes Marked* (Identify page numbers and section heading ) Throughout document Throughout document * Changes marked should detail the section(s) of the document that have been amended, i.e. page number and section heading. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG726 - ii -
5 NHS Grampian Protocol For The Provision Of Nicotine Replacement Therapy (NRT) For Patients With Nicotine Withdrawal Symptoms In Community Hospital By Registered Nurses Contents Page No 1. Introduction Informed Consent Patient Assessment Carried Out By A Trained Nurse Who Has Undergone Smoking Cessation Training Contra-indications, Precautions And Further Information Product Choice Recording, Provision And Administration Of NRT Products Ongoing Monitoring while an In-patient Discharge From Hospital References And Further Information Available From Consultation Group... 9 Appendix Appendix Appendix 3 Pathway To Support Patients With Nicotine Withdrawal Symptoms In Community Hospital Appendix 4 - Hospital In-Patient Smoking Cessation Clinical Pathway UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
6 NHS Grampian Protocol For The Provision Of Nicotine Replacement Therapy (NRT) For Patients With Nicotine Withdrawal Symptoms In Community Hospital By Registered Nurses 1. Introduction Community Hospitals in Grampian will be smoke free by March 2015; smoking is not permitted inside the building or in the grounds. This protocol details how to provide Nicotine Replacement Therapy (NRT) to in-patients who are smokers who cannot smoke while in hospital. Smokers who cannot smoke may have withdrawal symptoms which could result in restlessness, irritability, nervousness, headaches and cigarette craving. In terms of this protocol in-patients are defined as patients staying in hospital or individuals being assessed within Minor Injury Units aged 16 years of age and over. All patients admitted as an in-patient will be asked smoking status on admission following the Pathway To Support Patients With Nicotine Withdrawal Symptoms In Community Hospital (Appendix 3). This will allow staff to: Identify nicotine dependent patients. Provide patients with information about smoke free hospital and grounds. Offer patients who smoke support for symptoms of nicotine withdrawal in the form of NRT whether they plan to stop smoking or not. Advise patients at discharge on options for smoking cessation. GP must be informed that a patient is getting NRT so they can monitor the patient appropriately. Minor Injury Unit patients who request to smoke while being treated in the unit should be assessed using the Hospital In-Patient Smoking Cessation Clinical Pathway (Appendix 4). N. B. Electronic cigarettes are not recommended by NHS Grampian as part of an attempt to stop smoking as the current evidence on e-cigarettes remains weak and inconclusive and there is a lack of safety testing. 2. Informed Consent The patient s informed consent must be obtained before NRT can be provided; preferably written, either from the patient, parent, guardian or person with parental responsibility and documented either in the patient s medical records/notes or on an administration form. Consent must be in line with current NHSG Staff Policy for Obtaining Consent for Clinical Procedures and Healthcare Interventions. See link UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
7 3. Patient Assessment Carried Out By A Trained Nurse Who Has Undergone Smoking Cessation Training In order to decide on the level of NRT support required nursing staff must identify the level of nicotine dependence using the Hospital In-Patient Smoking Cessation Clinical Pathway algorithm (Appendix 3), which includes the Fagerstrom test. 1. When was your last cigarette? Record date. 2. How soon after waking do you smoke your first cigarette? Record score Over 60 mins (0) mins (1) 5-30 mins (2) within 5 mins (3) 3. How many cigarettes a day do you smoke? Record score 10 or less (0) (1) (2) 31+ (3) 4. Are you currently using NRT? Record answer Yes (record NRT) No (Continue pathway). 5. Does the patient want to stop smoking long term? Yes (refer to SAS and continue pathway) No (Continue pathway). Score: 1-2 = low dependence patient may not need NRT and is monitored for withdrawal symptoms. 3-4 = moderate dependence please check NRT recommendations Table = high dependence consider combination therapy, please check NRT recommendations in Table 1. Patients who are nicotine dependent should be offered NRT for symptomatic relief. In order to support patients who want to stop smoking on discharge they will be given a minimum of 7 days supply of NRT via a GP10 prescription and advised on the arrangements for future support. 4. Contra-indications, Precautions And Further Information Contra-indications Hypersensitivity to nicotine or any ingredient of the preparation being considered. A patient hospitalised for MI, severe dysrhythmia or CVA/head injury who is considered to be haemodynamically unstable should be encouraged to stop smoking with non-pharmacological interventions unless initiated by a doctor. These patients should be discussed with Smoking Advice Service who may then discuss with a GP if a prescription is being requested. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
8 Precautions Stopping smoking can affect the metabolism of certain medicines resulting in an increase in the blood levels of the medicine. Particular care is required for patients taking: o o o Warfarin Some anti-psychotics, e.g. clozapine, olanzapine Theophylline Skin disorders caution with patches Phenylketonuria caution with lozenges Gastrointestinal Disease caution with oral nicotine products Moderate or severe renal or hepatic impairment Phaeochromocytoma Uncontrolled hyperthyroidism Diabetes monitor blood sugar closely Pregnancy and lactation use short acting products. 5. Product Choice Discuss options with the patient. The choice of nicotine replacement preparations depends largely on patient preference and should take into account what preparations, if any, have been tried before and also on whether or not the patient is aiming to quit smoking completely. Nurses trained in smoking cessation may offer products in Table 1. Refer to current BNF for information on products available, their advantages/disadvantages and the relevant reducing dose titrations. If a medicine is not included in Table 1 it must be prescribed by an authorised prescriber before being administered to the patient. For Minor Injury Unit patients who smoke Every minutes administer one form of short acting NRT products to help with cravings. Use appropriate NRT product based on Fagersrtom Test. Advise on correct administration and do not exceed recommended dosage. Consider applying NRT patch if patient is likely to be admitted to hospital. For patients who will not smoke during their admission (i.e. will not go off-site to smoke) Nicotine patches are a prolonged release formulation and are applied for 16 hours (with the patch removed overnight) or for 24 hours. If the patient experiences strong cravings for cigarettes on waking, a 24 hour patch may be more suitable. Immediate release nicotine preparations (gum, lozenges, inhalator) are used whenever the urge to smoke occurs. Patients with a high level of nicotine dependence, or who have failed with nicotine replacement therapy previously may benefit from using a combination of a long acting preparation and an immediate release short acting preparation to achieve abstinence. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
9 For patients who are going to continue to smoke by going off-site during admission These patients should be informed of the risks involved when leaving the grounds and provided with short acting NRT, e.g. gum or lozenges or an inhalator to help with managing cravings. This should be provided at the appropriate strength on an as required basis for possible nicotine withdrawal effects due to a reduction in the amount of cigarettes smoked or if the patient craves a cigarette but is unable to smoke. For patients (16 years and older) staying in the hospital long-term who are using NRT while an in-patient or for patients who wish to stop smoking while in hospital Refer to the smoking advice service (freephone: ) advising that this is a hospital in-patient, to ensure that people receive the appropriate support and assistance with NRT management or stopping smoking. For patients (15 years and under) staying in the hospital or in the Minor Injury Unit Younger people with a high level of nicotine dependence should be discussed with the GP if NRT is being requested. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
10 Table 1 Only NRT detailed in the table below can be supplied by nurses trained in smoking cessation. Refer to BNF for detailed information on the complete range of NRT products available. If a medicine is required that is not detailed in Table 1 it must be prescribed on the Prescribing and Administration Record by an authorised prescriber before being administered to the patient. Long- Acting NRT Short- Acting NRT Short- Acting NRT Smoking Rate Moderate and high dependency NRT Low Dependency NRT > 20 Cigarettes/day Cigarettes/day <10 Cigarettes/day NICOTINE PATCH (Nicorette 16hr, Niquitin 24hr) Nicorette Nicorette Nicorette Invisi Patch Invisi Patch Invisi Patch (16 hour patch) (16 hour patch) (16 hour patch) 25mg patch 25mg patch 15mg patch NiQuitin Patch (24 hour patch) 21mg patch NICOTINE GUM or LOZENGE 4mg gum/lozenge Used as required, max 15/day. NiQuitin Patch (24 hour patch) 21mg patch 2mg gum/lozenge Used as required, max 15/day. NiQuitin Patch (24 hour patch) 14mg patch 2mg gum/lozenge Used as required, max 15/day. NICOTINE INHALATOR (Nicorette ) 15mg cartridges Used as required. A single 15mg cartridge lasts for approximately 40 minutes of intense use. Note: Not suitable for heavy smokers unless used in combination. Patients with obstructive respiratory disease may find it difficult to use. NICOTINE ORAL SPRAY (Nicorette Quickmist mouthspray) Use1-2 sprays in the mouth when the urge to smoke occurs or to prevent cravings Do not exceed 2 sprays per episode (up to 4 sprays every hour) Maximum of 64 sprays daily. Administration Apply one daily each morning. Remove 16 hour patch before bed. Remove 24 hour patch next morning. Apply fresh patch to alternative site. Gum: Chew the gum until the taste becomes strong, then rest it between the cheek and gum. When the taste starts to fade repeat this process. Patients with dentures may experience difficulty in chewing nicotine gum. The gum may stick to, and may in rare cases damage dentures. Lozenge: Slowly allow each lozenge to dissolve in the mouth; periodically move the lozenge from one side of the mouth to the other. Lozenges last for approximately minutes, depending on their size. Patients should not exceed 6 cartridges of the 15mg strength daily. Follow administration advice in the pack. Release one spray into the mouth, avoiding the lips. Do not inhale while spraying. Do not swallow for a few seconds after spraying. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
11 Combination Therapy Patients with a high level of nicotine dependence, or who have failed with nicotine replacement therapy previously may benefit from using a combination of a patch and an immediate release short acting preparation to achieve abstinence. Use a lower strength (2mg) lozenge or gum as required. 6. Recording, Provision And Administration Of NRT Products NRT products can be bought over the counter (OTC) by members of the public. In-patients - all medicines including OTC products must be recorded on the Prescribing and Administration Record as the use of these and the fact that the patient has stopped smoking can affect other medicines. Information must be completed as detailed in the Instructions for NHS Grampian Staff on the In-Patient Prescribing and Administration of Medicines using the NHS Grampian Prescription and Administration Record. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
12 Minor Injury Unit Patients all medicines supplied or administered must be recorded on ADASTRA or on the NHS Grampian Casualty Unit sheet. Nurses who have attended appropriate smoking cessation training may assess any patient who wants NRT support and agree which products will be used. Products used can only be those listed in this protocol. If a patient requests other products they should be referred to the smoking cessation service. Ward nurse must make an entry in the Patients Prescribing and Administration Record of all products being used. Check the allergy section for any known adverse effects to NRT products. NRT patches should be written in the Regular Therapy section. Administration should be recorded in the usual way. Short acting NRT products should be written in the As required section. The product and quantity that will be supplied to the patients should be recorded. The Prescriber signature box must be signed by the nurse carrying out the assessment and agreeing with the patient the products to be used. NRT Protocol must be entered in the Additional Instructions box. Minor Injury Unit nurse to make an entry on ADASTRA or in the NHS Grampian Casualty Unit sheet in accordance with local guidance. Check the allergy section for any known adverse effects to NRT products. Nurses to make a paper referral to smoking cessation services for those patients motivated to quit smoking and requesting additional support through either the smoking cessation service OR the pharmacy smoking cessation service. If no smoking cessation trained nurses are on duty a doctor should be asked to prescribe NRT. 7. Ongoing Monitoring while an In-patient Monitor for changes in the use of NRT products and smoking status. GP must assess the potential effect on other medicines medical/ conditions. 8. Discharge From Hospital On discharge Ward in-patients discharged and triaged as motivated to stop smoking will be: Referred to either : o The Smoking Advice Services (SAS), using a telephone referral (Tel: ), including the comment referred from a community hospital. Or o Their local Community Pharmacy. Advised on the option to continue smoking cessation, using the pharmacy smoking cessation services or the Smoking Advice Services. Offered a 7 day supply of NRT (via a GP10 prescription) to help to deal with the urge for tobacco products. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
13 Informed that the SAS may ask questions about the patient s smoking status. Patients who want to stop smoking on discharge should be given a minimum of a 7 days supply of NRT via a GP10 prescription and advised on future support. 9. References And Further Information Available From Summary of Product Characteristics and Patient Information Leaflets, Nicorette and Niquitin, Electronic Medicines Compendium, NHS Grampian Joint Formulary NHS Grampian Guidance on Smoking Cessation and Psychotropic Drug Interactions. BNF Number 67 March Consultation Group Louise Black Gladys Buchan Wendy Grant Dr P. Guthrie Wendy Innocent Denise Kazmierczak Derek Petrie George Rutten Lead Pharmacist, Aberdeenshire CHP Operational Lead Nurse, Aberdeenshire CHP Charge Nurse, Turriff Medical Practice GP, Turriff Medical Practice Smoking Advise Services Tobacco Training and Development Co-ordinator Tobacco Control Advanced Public Health Coordinator UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
14 Appendix 1 Health Care Professional Agreement For The Provision Of Medicines In Accordance With NHS Grampian Protocol I: (Insert name) Working within: e.g. CHP, Practice Agree to administer medicines under the direction contained within the following protocol NHS Grampian Protocol For The Provision Of Nicotine Replacement Therapy (NRT) For Patients With Nicotine Withdrawal Symptoms In Community Hospital By Registered Nurses I have completed the appropriate training to my professional standards enabling me to administer/supply medicines under the above Protocol. I agree not to act beyond my professional competence nor outwith the recommendations of the Protocol. Signed: Print Name: Date: NMC Registration No: UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
15 Appendix 2 Certificate Of Authorisation For The Provision Of Medicines Under Protocol This authorises: Working within: e.g. CHP, Practice To administer/supply medicines under the following Protocol NHS Grampian Protocol For The Provision Of Nicotine Replacement Therapy (NRT) For Patients With Nicotine Withdrawal Symptoms In Community Hospital By Registered Nurses The above named person has satisfied the training requirements and is competent to administer/supply medicines under the above Protocol. The above named person has agreed not to act beyond their professional competence nor out with the recommendations of the Patient Group Direction Signed: Authorising Manager/Doctor Print Name: Date: UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
16 Appendix 3 Pathway To Support Patients With Nicotine Withdrawal Symptoms In Community Hospital This flowchart shows the pathway to follow in raising the subject of smoking with a patient admitted to a Hospital. Find out first if the patient is smoking as part of the Patient Admission Assessment Document. If the patient does smoke, find out if they are interested in stopping and then offer the best help available. Note: Smoking is not permitted inside the hospital building or hospital ground. Inform patients wishing to smoke of the risk of going off the hospital ground to smoke. Patient Assessment Document Ask: Do you smoke? Document response in 3.Breathing No Congratulate Continue questions Patient Assessment Document Yes Explain that the hospital is a smoke free hospital and that the patient may be referred to a smoking advice service. Explain that smoking is not permitted in the hospital premises or outside on the hospital ground. Explain the patient will be visited for smoking advice at a more appropriate time. Continue with the Patient Assessment Document questions Revisit the patient Explain that you come to offer help. Smoking is not permitted inside the hospital or on the hospital ground. Explain you can offer help to control cravings for tobacco. Continue Ask: Are you interested in trying to stop and, if so, do you feel motivated to stop now or in the near future? No Briefly outline the health risks of smoking and the benefits of stopping (can be related to the patient s condition). Yes Ask: Would you like help from the stop smoking services provided in the hospital? Yes Explain to the patient that you can provide products to increase the chances of stopping smoking and staying stopped. Explain the range of NRT products available Ask: Would you like to use NRT or other medication? No No Accept answer without judging. Explain that smoking is not permitted inside the hospital or hospital ground. Advise patient of risks of going off site to smoke Explain briefly that there is a range of services (smoking advice service/ pharmacist) and a range of products (long term NRT/ short term NRT) available to reduce the urge to smoke Confirm: Would you like to use NRT or other medication? No Give: Information on how to stop smoking and support available (e.g. leaflet) Remind patient smoking is not permitted in the hospital or on the hospital ground. Patient can ask for help anytime for support to control cravings for tobacco. Yes Yes Continue with the hospital in-patient smoking cessation clinical pathway; Assess (condensed Fragerstrom test): 1. When was your last cigarette? Record date. 2. How soon after waking do you smoke your first cigarette? Record score Over 60 mins (0) mins (1) 5-30 mins (2) within 5 mins (3) 3. How many cigarettes a day do you smoke? Record score 10 or less (0) (1) (2) 31+ (3) 4. Are you currently using NRT? Record answer Yes (record NRT) No (Continue pathway). 5. Does the patient want to stop smoking long term? Smoking Advice Service: Yes (refer to SAS and continue pathway) No (Continue pathway). Mention a referral from a hospital Total score 2+3: 1-2 = low tobacco dependence 3-4 = mod tobacco dependence 5+ = high tobacco dependence Continue with Hospital In-patient Smoking Cessation clinical pathway form UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
17 Appendix 4 - Hospital In-Patient Smoking Cessation Clinical Pathway To be used for patients admitted to a hospital and identified as a current smoker in the Patient Admission Assessment Document. Use in combination with Protocol for the Provision of NRT for Nicotine Withdrawal Symptoms in Community Hospital In-Patients Smoking Cessation Clinical Pathway CHI: Name: Address: DoB: (affix identification label here) Male / Female Ask Assess Date: 1. When was your last cigarette? Date: / / 2. How soon after waking do you smoke your first cigarette? Over 60 mins (0) mins (1) 5-30 mins (2) within 5 mins (3) 3. How many cigarettes a day do you smoke? Total score 2+3: 10 or less (0) (1) (2) 31+ (3) 1-2 = low tobacco dependence 3-4 = mod tobacco dependence 4. Are you currently using NRT? 5+ = high tobacco dependence Yes No Continue pathway. Initial Assist Treatment options For complete range refer to BNF For administration usage check Protocol for NRT Smoking Advice Service Ask: Are you nicotine dependent? Do you need NRT? Moderate and high dependency NRT Low dependency NRT No need NRT Products to choose from Long- Acting NRT Smoking Rate > <10 Cigarettes/day Cigarettes/day Cigarettes/day NICOTINE PATCH (Nicorette 16hr, Niquitin 24hr) Nicorette Patch Nicorette Patch Nicorette Patch (16 hour patch) (16 hour patch) (16 hour patch) 25mg patch 25mg patch 15mg patch NiQuitin Patch (24 hour patch) 21mg patch NiQuitin Patch (24 hour patch) 21mg patch NiQuitin Patch (24 hour patch) 14mg patch Behavioural support Continue next page for short acting NRT. UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
18 Continued from previous page. Moderate and high dependency NRT Low dependency NRT No need NRT Products to choose from Short- Acting NRT Smoking Rate > Cigarettes/day Cigarettes/day NICOTINE GUM or LOZENGE 4mg gum/lozenge 2mg gum/lozenge Used as required, Used as required, max 15/day. max 15/day. <10 Cigarettes/day 2mg gum/lozenge Used as required, max 15/day. Behavioural support Short- Acting NRT NICOTINE INHALATOR (Nicorette ) 15mg cartridges Used as required. Patients should not exceed 6 cartridges of the 15mg strength daily. NICOTINE ORAL SPRAY (Nicorette Quickmist mouthspray) Use1-2 sprays in the mouth when the urge to smoke occurs or to prevent cravings Up to 4 sprays every hour. Maximum 64 sprays daily. Record product used in NHS Grampian Prescription and Administration Record Sheet and patient clinical notes Arrange follow up Hospital discharge date Have patient clinical notes been completed? Does the patient want to stop smoking long term? - Yes: Explain options; Smoking Advice Service or pharmacy Patient indicated wanting a referral to (please tick): Smoking Advice Service Call: Pharmacy Provide patients with mod/ high nicotine dependency with NRT for 7 days. Record product used. Completion date: - No: Remind the patient of the services that are available to stop smoking UNCONTROLLED WHEN PRINTED Review Date: March 2017 Identifier: NHSG/Prot/NRT_InPat/MGPG
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Derbyshire Formulary for Nicotine Replacement Therapy (NRT) 1. Supporting Smokers to stop smoking The most effective method to quit smoking is by quitting
More informationThis letter authorises the extended use of the following guidance until 1st June 2019:
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 13Th November 2018 Our Ref: FA_ONS_Guide/MGPG/Nov18 Enquiries to: Frances Adamson Extension: 56689 Direct Line:
More informationConsultation Group: Lead Community Dietitians Aberdeen, Aberdeenshire and Moray CHP. Review Date: October Uncontrolled when printed.
Policy For The Prescribing and Administration Of Oral Nutritional Supplements In Adults By General Practitioners And Primary Care Staff Working Within NHS Grampian Co-ordinators: Dietetic Prescribing Advisor,
More informationPGD5717. Director of Quality & Clinical Performance. Therèsa Moyes
PGD5717 Patient Group Direction Administration of Nicotine Lozenges 4mg, Sublingual Tablets 2mg or Mouth Spray By Registered Nurses employed as by South Staffordshire & Shropshire Healthcare Foundation
More informationSECTION 17: NICOTINE REPLACEMENT. Formulary and Prescribing Guidelines
SECTION 17: NICOTINE REPLACEMENT Formulary and Prescribing Guidelines 17.1 Introduction These guidelines should be used in conjunction with EPUT No Smoking Policy (HRP20) for service users who are 12 years
More informationFormulary and Prescribing Guidelines
Formulary and Prescribing Guidelines SECTION 17: NICOTINE REPLACEMENT THERAPY 17.1 Introduction These guidelines should be used in conjunction with SEPT No Smoking Policy (HRP20) and for service users
More informationPatient Group Direction for the Supply of Varenicline (Champix ) by Authorised Community Pharmacists
Patient Group Direction for the Supply of Varenicline (Champix ) This Patient Group Direction (PGD) is a specific written instruction for the supply of varenicline to groups of patients who may not be
More information5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.
0 11 Key Messages 1. Ask and document smoking status for all patients. 2. Provide brief advice on quit smoking at every visit to all smokers. 3. Use individual, group and telephone counselling approaches,
More informationNicotine Management and Smoke Free
Nicotine Management and Smoke Free From 31 May 2016 Information for Service Users Why are we smoke free? l Tobacco smoking is the largest cause of early deaths and preventable illnesses in England. l One
More informationCustomize Your Quit \ 2 1 / Tailored treatment to help stop smoking. Customize Your Quit. Customize Your Quit
1 / \ 2 Customize Your Quit McNeil Consumer Healthcare, division of Johnson & Johnson Inc., Markham, Canada L3R 5L2 Johnson & Johnson Inc. 2017 PSNRT15-80E Tailored treatment to help stop smoking 3 / \
More informationDate 29 th March 2018 Our Ref FA_Anticoag/MGPG/Mar18 Enquiries to Frances Adamson Extension Direct Line tadamson(anhs.
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date 29 th March 2018 Our Ref FA_Anticoag/MGPG/Mar18 Enquiries to Frances Adamson Extension 56689 Direct Line 01224 556689
More informationProcedure for Nicotine Replacement Therapy on Inpatient Units
Procedure for Nicotine Replacement Therapy on Inpatient Units PROCEDURE NO CL 005????? DATE RATIFIED December 2014 REVIEW DATE December 2017 APPROVED BY Drugs and Therapeutics ACCOUNTABLE DIRECTOR Chief
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SMOKING CESSATION Introduction NICE recommends that Nicotine Replacement Therapy (NRT), bupropion [Zyban ] and
More informationStop smoking products guidance
Stop smoking products guidance Ref: Status: Approved Stop smoking products guidance Page 1 of 15 Approval date: 22 November 2018 Contents 1. Purpose... 3 2. Related documents... 3 3. Guidance... 3 3.1
More informationNicotine Replacement Therapy (NRT).
Nicotine Replacement Therapy (NRT). Information for smokers 1 What is NRT? The aim of Nicotine Replacement Therapy (NRT) is to reduce the withdrawal symptoms associated with nicotine addiction by replacing
More informationGuidelines for. Nicotine Replacement Therapy. Issuing of Vouchers. For use by the Stop Smoking in Pregnancy Service
Guidelines for Nicotine Replacement Therapy Issuing of Vouchers For use by the Stop Smoking in Pregnancy Service DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Effectiveness Committee Date ratified:
More informationService Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle
Service Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle Contents 1. Agreement period 2. Scope 3. Targets 4. Service outline 5. Support for clients using
More informationNHS Grampian Guidance For Staff Working In The Mental Health Service For The Use Of High-Dose Antipsychotic Medication
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS Date 20 th November 2014 Our Ref HDAT_MGPG/Nov14 Enquiries to Caroline Hind Extension 56088 Direct Line 01224 556088 Email caroline.hind2@nhs.net
More informationProtocol for the Direct Supply of Nicotine Replacement Therapy by Competent Non-Clinical Advisors of The Stop Smoking Service in Norfolk
Appendix B Protocol for the Direct Supply of Nicotine Replacement Therapy by Competent Non-Clinical Advisors of The Stop Smoking Service in Norfolk Document Control Document name Protocol for the direct
More informationPATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN NHS LANARKSHIRE
PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN NHS LANARKSHIRE (Approved May 2014 - Review Date May 2016) GENERAL POLICY PATIENT GROUP DIRECTION
More informationPATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN TAYSIDE
PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN TAYSIDE GENERAL POLICY 2 PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE 4 STANDING ORDER
More informationTitle: Approved By: Applicable to: Group D&T section of the AMD Dept./ Division Only No Directorate Only: No Trust-wide No
Title: CLINICAL GUIDELINES ID TAG Smoking Cessation Guideline for the Prescribing, Issue and Administration of Nicotine Replacement Therapy on Inpatient Wards Lyn Watt Pharmacy Patient Services Manager
More informationJob Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014
PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN FORTH VALLEY Protocol Number 445 Version 1 Date protocol prepared: June 2014 Date protocol due
More informationNHSG/Pol/OralNut/MGPG639
Title: Identifier: Policy And Procedure For General Practitioners And Primary Care Staff For Managing Malnutrition And Prescribing Oral Nutritional Supplements In Adults NHSG/Pol/OralNut/MGPG639 Replaces:
More informationPatient Group Direction for the Supply of Nicotine Replacement Therapy, (NRT) (Smoking Cessation Service for Pharmacies in Kent)
Patient Group Direction for the Supply of Nicotine Replacement Therapy, (NRT) (Smoking Cessation Service for Pharmacies in Kent) Written by: Marion Walton, Pharmacist Advanced, Adult Services Date: February
More informationCAMBRIDGESHIRE & PETERBOROUGH STOP SMOKING SERVICE S. Stop Smoking Pharmacological Products Guidance
CAMBRIDGESHIRE & PETERBOROUGH STOP SMOKING SERVICE S Stop Smoking Pharmacological Products Guidance This guidance is for use by Cambridgeshire Stop Smoking Service (CAMQUIT), Peterborough Stop smoking
More informationfor adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services
The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service
More informationNHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery
Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery Co-ordinators: Dr Karen Cranfield, Consultant Anaesthetist, Lead Acute Pain Sector
More informationBRIGHTON & HOVE NICOTINE REPLACEMENT THERAPY (NRT) VOUCHER SCHEME
BRIGHTON & HOVE NICOTINE REPLACEMENT THERAPY (NRT) VOUCHER SCHEME A voucher scheme is commonly used instead of, or sometimes as well as, GP prescriptions (FP10) and PGDs. The Brighton & Hove nicotine replacement
More informationDispensing of Nicotine Replacement Therapy (NRT)
Simcoe Muskoka District Health Unit Print Version Medical Directive Number: Topic: Dispensing of Nicotine Replacement Therapy (NRT) Revised: October 2011 Approved: May 21, 2007 Description Nicotine Replacement
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF VARENICLINE (CHAMPIX ) TO ADULTS OVER 18 YEARS OF AGE BY COMMUNITY PHARMACISTS UNDER THE PUBLIC HEALTH SERVICE - SMOKING CESSSATION SERVICE IN NHS HIGHLAND THE
More informationConsultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off
Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes
More informationNHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5
NHS...... Grampian Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults Co-ordinators: Consultant Anaesthetist, Lead Acute Pain
More informationPROTOCOL FOR A NICOTINE REPLACEMENT THERAPY (NRT) VOUCHER SCHEME
PROTOCOL FOR A NICOTINE REPLACEMENT THERAPY (NRT) VOUCHER SCHEME PREPARED BY: Kirklees Public Health on behalf of the Council of the Borough of Kirklees FIRST ISSUED: 1 st April 2017 TO BE REVIEWED: 31
More informationSmokefree Wiltshire. Information leaflet. Planning to quit? Find the right support for you.
Smokefree Wiltshire Information leaflet Planning to quit? Find the right support for you www.wiltshire.gov.uk/smokefree Support for smokers Smokefree Wiltshire offers tailored stop smoking support for
More informationA new model for prescribing varenicline
Pharmacist Independent Prescribers in partnership with A new model for prescribing varenicline Dear Stop Smoking Advisor You will be aware of the stop smoking drug varenicline that goes under the brand
More informationEffective date: October 15, 2009
COLLECTIVE PRESCRIPTION Start According to a protocol: Yes No Effective date: October 15, 2009 Next review date: October 15, 2012 Professionals who can dispense the prescription Community pharmacists working
More informationTobacco Dependence Treatment Pathway
Tobacco Dependence Treatment Pathway GUIDELINE VERSION 1 RATIFYING GROUP Drugs and Therapeutics Group (DTG) DATE PUBLISHED January 2017 NEXT REVIEW DATE January 2019 FORMULARY SPONSOR Executive Medical
More informationNHS FORTH VALLEY Stop Smoking Guidance
NHS FORTH VALLEY Stop Smoking Guidance Date of First Issue 28/06/2012 Approved 28/06/2012 Current Issue Date 22/01/2018 Review Date 22/01/2021 Version Version 2 EQIA 01/05/2018 Author / Contact Scott Robertson,
More informationTWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION
Appendix G PHASE OF MANAGEMENT NOTIFICATION ASSESSMENT TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION ACTIONS All patients will be advised on admission that :
More informationDate: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs.
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: 56689 Direct Line: 01224 556689
More informationSMART STEPS towards a tobacco-free life
SMART STEPS towards a tobacco-free life Ready to Quit Smoking? You decide when. We ll show you how. Smart steps... Ready to Put Tobacco Behind You? Congratulations on deciding to quit! Quitting tobacco
More informationNicAssist 2 mg Lozenge (Nicotine)
Information for the user NicAssist 2 mg Lozenge (Nicotine) Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription to help
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationNicotine Replacement Therapy Inpatient Prescribing Guideline
SH CP 187 Nicotine Replacement Therapy Inpatient Prescribing Guideline Summary: Nicotine replacement therapy prescribing guideline (does not cover e-cigarettes and similar products) Keywords (minimum of
More informationQuit with Us. Service Evaluation. August 2016
Quit with Us Service Evaluation August 2016 Contents 1. Executive Summary... 1 2. Introduction... 1 3. Background... 1 4. Data Collection Methods... 1 5. Results... 1 6. Preferred smoking quit methods...
More informationNRT Voucher redemption scheme service specification
NRT Voucher redemption scheme service specification Updated March 2016 Review date March 2018 Page 1 of 7 1. Introduction The NRT voucher scheme is for NHS Fife stop smoking advisors who have been deemed
More informationSmoking Cessation Pharmacotherapy Guidelines
Smoking Cessation Pharmacotherapy Guidelines INTRODUCTION This guideline is based on public health guidance 10 Smoking Cessation Services issued by the National Institute for Health and Clinical Excellence
More informationPATIENT GROUP DIRECTION for the Supply of: Varenicline (Champix ) tablets. By: Accredited Pharmacists
PATIENT GROUP DIRECTION for the Supply of: Varenicline (Champix ) tablets By: Accredited Pharmacists In: Community Pharmacies in [insert area] accredited by [insert council] It is the responsibility of
More informationNational Patient Group Direction for the Supply of Azithromycin, by Pharmacists, for the Treatment of Uncomplicated Chlamydia Infection
National Patient Group Direction for the Supply of Azithromycin, by Pharmacists, for the Treatment of Uncomplicated Chlamydia Infection UNCONTROLLED WHEN PRINTED EFFECTIVE FROM NOVEMBER 2010 REVIEW DATE
More informationQuitting is all about finding what works for you.
Quitting is all about finding what works for you. Your guide to finding the right support 02 Smokefree Your way Well done you I can do it! Smokefree provides advice, support and encouragement to help people
More informationCENTRE FOR ADDICTION AND MENTAL HEALTH -MEDICAL DIRECTIVE ADMINISTRATION OF NICOTINE REPLACEMENT MEDICATIONS BY REGISTERED NURSES
CENTRE FOR ADDICTION AND MENTAL HEALTH -MEDICAL DIRECTIVE TITLE: ADMINISTRATION OF NICOTINE REPLACEMENT MEDICATIONS BY REGISTERED NURSES POLICY #: D24 ORIGINATOR: Nicotine Dependence Clinic APPROVAL DATE:
More information21 INSTRUCTOR GUIDELINES
STAGE: Ready to Quit Ms. Crosby is a 32-year-old woman who recently began attending a worksite group program for smoking cessation. Her group has set a quit date for one week from today, and she would
More informationLocally Enhanced Service for Stopping Smoking
NHS Devon Locally Enhanced Service for Stopping Smoking This Local Enhanced Service (LES) Specification details the agreement between Devon PCT (the commissioner) and community pharmacies (the service
More informationNHS Grampian Tobacco Policy 2016
NHS Grampian Tobacco Policy 2016 Co-ordinator: Tobacco Policy Review Group Reviewer: GAPF Policies Subgroup Approver: Grampian Area Partnership Forum (GAPF) Revised 2016 Review date: 2017 Uncontrolled
More informationNicotine Replacement Therapy, Zyban and Champix. Name of presentation
Nicotine Replacement Therapy, Zyban and Champix Nicotine Replacement Therapy (NRT) - Rationale for use Nicotine is highly addictive and causes unpleasant withdrawal symptoms which often undermine a quit
More informationTherapy Activation Date: Review Date:
MEDICAL DIRECTIVE Title: Nicotine Replacement Number: TCFHT-MD10 Therapy Activation Date: 14-06-2011 Review Date: 01-05-2016 Sponsoring/Contact Person(s) (name, position, contact particulars): Sherry Kennedy,
More informationBrighton and Hove Pharmacy Enhanced Service (PLES 02)
Brighton and Hove Pharmacy Enhanced Service (PLES 02) Smoking Cessation Service (2007/08) This enhanced service is aimed at clients who are non-complex cases and would like to be supported and be managed
More informationREGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide
REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY 2009 A Pharmacist s Guide Aims of the Service The overall aim of the service is to deliver a pharmacy based, one stop specialist smoking
More informationBoots NicAssist Fruit Fresh Gum (Nicotine)
Information for the user Boots NicAssist Fruit Fresh Gum (Nicotine) Boots NicAssist Fruit Fresh 2 mg Gum Boots NicAssist Fruit Fresh 4 mg Gum Read all of this leaflet carefully because it contains important
More informationPrescribing guidance in. Smoking Cessation March 2011
Prescribing guidance in Smoking Cessation March 2011 The aim of this guidance is to update previous prescribing guidance (2007) ensuring that there is a consistent approach throughout Dumfries & Galloway
More informationGuidance For The Use Of Lofexidine In The Symptomatic Management Of Opioid Withdrawal By Clinicians Working Within NHS Grampian. Consultation Group:
NHS...Ness Grampian Guidance For The Use Of Lofexidine In The Symptomatic Management Of Opioid Withdrawal By Clinicians Working Within NHS Grampian Co-ordinators: Specialist Pharmacists in Substance Misuse
More informationSmoking Cessation Services Guidance
Smoking Cessation Services Guidance Alabama Medicaid Tobacco Treatment Coverage Covered Services/Medication 1. Free tobacco cessation counseling is provided through the Alabama Tobacco Quitline. Refer
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2017
Patient Group Direction For Supply Of Paracetamol Oral Suspension 120mg/5mL For Prevention Of Post Immunisation Fever Following Administration Of Meningococcal Group B Vaccine (Bexsero ) By Community Pharmacists
More informationStop. Stop before your op. Living. Start. Helping you cut out smoking for good. NHS Foundation Trust
Stop before your op Stop Smoking Start Living Helping you cut out smoking for good NHS Foundation Trust Stop before the op Current evidence shows that you should aim to quit smoking at least 8 weeks before
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More informationTobacco use assessment, brief counseling,, and quit line referral
Tobacco use assessment, brief counseling,, and quit line referral What is the evidence for tobacco cessation counseling? Tobacco use is the leading cause of preventable death in the US 1 Counseling and
More informationpatient group direction
SALBUTAMOL v01 1/12 SALBUTAMOL PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner
More informationMy Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon.
My Mask KL I keep it all inside Because I d rather The pain destroy me Than everyone else. Anon. 43 K. N. Roy Chengappa, M.D., FRCPC Professor of Psychiatry, University of Pittsburgh School of Medicine,
More informationClearing the Air: What You Need to Know and Do to Prepare to Quit Smoking
Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course Creating Success! THINK ABOUT Process of Changing an Addiction Your Pros and Cons of Smoking and Quitting
More informationGuidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian
Title: Identifier: Guidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian NHSG/Guide/NHSG_NaltexMA_885 Replaces:
More informationOur Smokefree Trust. Patient Information Leaflet. Easy Read
Our Smokefree Trust Patient Information Leaflet Easy Read A member of staff or a carer can support you to read this booklet. They will be able to answer any questions that you have. This leaflet will tell
More informationThe health risks of smoking
John Bell Counter says Connection Smoking cessation Pharmacy assistant s education Module 229 Smoking cessation By Lynn Greig This education module is independently researched and compiled by PSA-commissioned
More informationIntroduction to pharmacotherapy
Introduction to pharmacotherapy Dr. Shamim Jubayer. Research Fellow Dept. Epidemiology and Research National Heart Foundation Hospital And research Institute Effective tobacco cessation medications The
More informationSmoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service
Smoke-free Hospitals Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Today s Subjects 5A s and Clinician Training and Use with the Hospitalized Patient NRT use in
More information7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING PDF YOU CAN QUIT SMOKING. QUIT SMOKING CDC 1 / 5
7 DAY QUIT SMOKING PDF YOU CAN QUIT SMOKING. QUIT SMOKING CDC 1 / 5 2 / 5 3 / 5 7 day quit smoking pdf 7 Your guide to quitting smoking This guide is for smokers who want to quit and stay quit. Just like
More informationCessation of Smoking By Nicotine Replacement Therapy
Review Article ISSN: 0974-6943 Mamatha. J et al / Journal of Pharmacy Research 2017,11(5), Available online through http://jprsolutions.info Cessation of Smoking By Nicotine Replacement Therapy Mamatha.
More informationSTOP SMOKING with Nicotine Replacement Therapy
STOP SMOKING with Nicotine Replacement Therapy Gita Anjali Shah, Clinical Pharmacist, UK and Guest Lecturer, Faculty of Pharmacy, Mahidol University Shocking Statistics According to the last Global Adult
More informationGuidance for the Management of Smoking Cessation within Sirona Care & Health and Providers in the Community
Guidance for the Management of Smoking Cessation within Sirona Care & Health and Providers in the Community This guidance should be used in close conjunction with the referenced guidelines, in particular
More informationInitiation of Clozapine Treatment Community Patients
Initiation of Clozapine Treatment Community Patients Who Should Read This Policy Target Audience All clinical staff working in the community N/A N/A Initiation of Clozapine Treatment for Patients in the
More informationGuidance For The Development And Implementation Of Patient Group Directions (PGDs) For Staff Working Within NHS Grampian. Consultation Group:
NHS...... Grampian Guidance For The Development And Implementation Of Patient Group Directions (PGDs) For Staff Working Within NHS Grampian Co-ordinators: Medicines Management Specialist Nurse Consultation
More informationLet s Quit Together.
Let s Quit Together. Are you ready to quit smoking? Whether it s your first time quitting, or you ve been trying for years, CVS/pharmacy and MinuteClinic are here to help with information, tools, guidance
More informationGuidance For NHS Grampian Clinicians On The Management Of Insomnia And The Use Of Hypnotics
Guidance For NHS Grampian Clinicians On The Management Of Insomnia And The Use Of Hypnotics Co-ordinators: Specialist Pharmacists in Substance Misuse Reviewer: Bruce Davidson Consultant Psychiatrist and
More informationHealth Professional Manual
Health Professional Manual Session: Smoking Cessation Smoking and COPD Strategies for quitting smoking Adapted from the Living Well with COPD program (2nd edition), Montreal Chest Institute, Canada SESSION
More informationWest R, Shiffman S. Fast facts smoking cessation. Oxford: Health Press Limited, 2004.
Research shows that smokers who use licensed nicotine replacement therapy and receive specialist stop smoking support are four times more likely to quit smoking for good. West R, Shiffman S. Fast facts
More informationPROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11. Administration
PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11 NAME OF PROCEDURE: REASON FOR THE PROCEDURE: WHAT THE PROCEDURE WILL ACHIEVE: Medicines Procedure: Homely Remedies Administration Guidance on administration
More informationPATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY Version Number: 5 Patient Group Direction drawn up by: Name Ray Lyon Dr Al Amaladoss
More informationTobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing GOAL To build the capacity of prescribing clinicians in behavioral health settings to integrate best practices for prescribing
More informationPatient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationFencino patch (5) 2. Check the practice has agreed to the protocol and a signed copy is in place.
Switch protocol: Fentanyl/Durogesic patches to Fencino /Matrifen /Mezolar brand switch Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the
More informationAWMSG members are asked to consider the update of the All Wales Guide: Pharmacotherapy for Smoking Cessation for endorsement.
Enclosure No: Agenda Item No: Author: Contact: 10/AWMSG/0218 15 All Wales Guide: Pharmacotherapy for Smoking Cessation Rosemary Allgeier, Principal Pharmacist in Public Health, Public Health Wales Tel:
More informationReady to give up. Booklet 3
Ready to give up Booklet 3 This booklet is written for people who have decided that they want to stop smoking. You can use this booklet on its own or go through it with the person who gave it to you. You
More informationCore Competencies - Smoking Cessation Fundamentals
Core Competencies - Smoking Cessation Fundamentals This training standard was developed for the National Training Service (NTS) Alliance in consultation with subject matter experts. The purpose of this
More informationConsultation Group: Cardiology Consultants Clinical lead for cardiology: Dr Andrew Hannah. Review Date: Uncontrolled when printed.
NHS Grampian Staff Guidelines For The In-Hospital Management Of Unstable Angina And Non-ST-Segment- Elevation Myocardial Infarction Patients (17 Years And Older) Co-ordinators: Cardiology Specialist Clinical
More informationNicAssist 15 mg Inhalator (Nicotine)
Information for the user NicAssist 15 mg Inhalator (Nicotine) Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription to help
More informationContents. Smoking. Staying stopped. Preparing to stop. Relapsing. Stopping
Contents Stage 1: Preparing to stop smoking 1 Stage 2: Stopping 3 Stage 3: Staying stopped 5 Nicotine replacement therapy 7 Non-nicotine treatments 10 Where to get help and advice 11 Stopping smoking isn't
More informationBest Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree
Best Practice for Smoking Cessation: Pharmacotherapy Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree Why is it so hard to quit? People who smoke aren t weak
More informationSmoking cessation therapy
Appendix 1 Smoking cessation therapy Q. Can a dentist prescribe medications for smoking cessation? A. Yes. Dentists are allowed and are encouraged to help patients with smoking cessation by counseling
More informationThis letter authorises the extended use of the following guidance until 1st December 2018:
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date 29 1h May 2018 Our Ref FApenicillin/hype/MGPG/May 18 Enquiries to Frances Adamson Extension 56689 Direct Line 01224
More information